Intercell Announces Pediatric Approval of its Japanese Encephalitis Vaccine in the U.S.

Press Wire ♦ Published: May 21, 2013; 08:31 ♦ (Vindobona)

Intercell Announces Pediatric Approval of its Japanese Encephalitis Vaccine in the U.S.

Intercell Announces Pediatric Approval of its Japanese Encephalitis Vaccine in the U.S. / Picture: © Vindobona.org
Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement.

Company Information

Wien (euro adhoc) - Vienna (Austria), May 21, 2013 - Intercell AG (VSE; "ICLL")
announced today that the pediatric indication for IXIARO®, a vaccine to protect
against Japanese Encephalitis (JE), was…

or Log In

Fast News Search
Read More
Intercell
ISIN
AT0000612601
Featured
See latest Vindobona Newsletter